about
Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.Synergizing vaccinations with therapeutics for measles eradicationWaiting time to infectious disease emergenceEstimating the measles effective reproduction number in Australia from routine notification data.Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.Largest measles epidemic in North America in a decade--Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events.Detecting differential transmissibilities that affect the size of self-limited outbreaks.Inference of R(0) and transmission heterogeneity from the size distribution of stuttering chainsEvidence-based clinical guidelines for immigrants and refugees.Measles in Canada Between 2002 and 2013.Nine challenges in modelling the emergence of novel pathogensElimination of endemic measles transmission in AustraliaComparing methods for estimating R0 from the size distribution of subcritical transmission chains.Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.The Threat and Response to Infectious Diseases (Revised).Whole-Genome Sequencing of Measles Virus Genotypes H1 and D8 During Outbreaks of Infection Following the 2010 Olympic Winter Games Reveals Viral Transmission Routes.Polio virus neutralizing antibody dynamics among children in a north-central and South-Western Nigeria state.Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.Rubella diagnostic issues in Canada.Measles surveillance in Canada: Trends for 2014.Measles surveillance in Canada: 2015.Measles surveillance in Canada: Trends for 2013.Outbreak of measles in an unvaccinated population, British Columbia, 2014.Maintaining measles elimination in Canada: Moving forward.Measles activity in Canada: January - June 2014.
P2860
Q25256812-8A88D231-D412-46F2-8EE7-625946B656F0Q27003149-81AD250C-201C-4836-B109-5B6B7D42783CQ27674436-D92A3649-823C-4318-A52D-7648FFB7ACEBQ30793607-B3527E5E-5C8F-4CFC-B8CD-278847D6B28EQ30835865-7535FD7B-6BE4-49CD-BB0D-6C07229D6D3CQ33908021-CA433C73-9602-4ECE-A06D-980D18C9AF94Q34319379-779494C9-CB07-473F-9B8A-E18E26F52759Q34428729-2F66F114-0FB8-4217-BC79-C8896F5DDECFQ34711751-713E1FC2-08BF-474B-BE8A-6C0B8997D83AQ35201293-55BD5D9F-ADD9-4D97-8D9F-6B26963CA22EQ35757369-376945F9-3FE6-40D4-91E3-25F56F90785BQ36468417-ED4CD0CF-4E86-42D5-B815-A0274DCB5B13Q37113309-37295385-526F-42F6-A7BE-1F1F45B7CCBDQ37289772-1A85AA48-D264-4C60-AA85-8B8C36646E7DQ37405340-1791BDA0-0551-4454-A63F-C32F0FD7F225Q38603782-21807D90-924F-4B71-B3ED-04662810FC6DQ40592880-B3FE91F0-2546-4C2E-9491-C66ACA14121BQ40759716-A835D78C-85E5-4AC9-9108-A5AF87A4A9C7Q42235323-031FFE15-D2AC-4E6D-9F07-DAAB19E01504Q50948541-5B6B1DD0-62B1-486E-BDDF-664F8F09028BQ51526548-F52B65A6-4551-401A-95A4-B9D7B58A57EEQ54978220-F86D94B6-20C8-453E-A664-F4FDBA10412FQ55012845-A5721CE2-7E83-4EE8-A20A-D70046430C85Q55030144-E451D816-99A2-4856-BE95-F484447843F5Q55129855-22620E70-0B30-4A27-881A-39F8C4B1CA61Q55221707-A66B6603-1BAC-4B8B-AF1E-007BC61D8FD7Q55434532-755E92FF-A7AA-4A3F-BF1B-E30A74D70860
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Measles elimination in Canada.
@en
Measles elimination in Canada.
@nl
type
label
Measles elimination in Canada.
@en
Measles elimination in Canada.
@nl
prefLabel
Measles elimination in Canada.
@en
Measles elimination in Canada.
@nl
P2093
P356
P1476
Measles elimination in Canada.
@en
P2093
Arlene King
Graham A Tipples
John Waters
Paul Varughese
Working Group on Measles Elimination
P304
P356
10.1086/378499
P407
P478
189 Suppl 1
P577
2004-05-01T00:00:00Z